陈邦华, 纪庆娥. 可逆性胆硷酯酶抑制剂二甲氨基甲酸-5-二氢吲哚酯的合成J. 药学学报, 1990, 25(4): 247-252.
引用本文: 陈邦华, 纪庆娥. 可逆性胆硷酯酶抑制剂二甲氨基甲酸-5-二氢吲哚酯的合成J. 药学学报, 1990, 25(4): 247-252.
BH Chen, QE Ji. SYNTHESIS OF INDOLINYL-N,N-DIMETHYLCARBAMATES AS REVERSIBLE ANTICHOLINESTERASE AGENTSJ. Acta Pharmaceutica Sinica, 1990, 25(4): 247-252.
Citation: BH Chen, QE Ji. SYNTHESIS OF INDOLINYL-N,N-DIMETHYLCARBAMATES AS REVERSIBLE ANTICHOLINESTERASE AGENTSJ. Acta Pharmaceutica Sinica, 1990, 25(4): 247-252.

可逆性胆硷酯酶抑制剂二甲氨基甲酸-5-二氢吲哚酯的合成

SYNTHESIS OF INDOLINYL-N,N-DIMETHYLCARBAMATES AS REVERSIBLE ANTICHOLINESTERASE AGENTS

  • 摘要: 为了深入研究催醒宁类化合物的结构与抑酶活性的关系,设计合成了-系列1-,3-或5-位不同取代的二氢吲哚类衍生物(中间体和终产物共24个新化合物)。中间体1,3-二甲基-5-烷氧基-2-二氢吲哚酮(A)的C3烷化。采用相转移催化方法进行;反应中还分离到三个副产物(Ⅶ~Ⅸ)。初筛结果表明:这些化合物大多有较强的抑酶活性;1,3-或5-位取代基的改变均明显影响其活性。

     

    Abstract: A series of new indolinyl derivatives (Ⅰ1~5, Ⅱ1~3 and Ⅲ1~8) with different substituents at 1-,3-or 5-position were synthesized in order to study the relationship of structure and anticholinesterase activities of CUI XING NING and its derivatives. The method of phase transfer catalysis was successfully applied in the C3-alkylation of intermediate A as well as in the N-alkylation and the carbamylation. Three by-products were obtained during the C3-alkylation and their structures and all of the structures of the 24 new compounds (including the intermediats) were identified by spectral and elementary analysis. Preliminary pharmacologic tests showed that most of the compounds have potent anticholinesterase activities. All of the substituents of 1-, 3-or 5-position of the compounds may affect their activities (see Table 4).

     

/

返回文章
返回